StockWatch
·
Pharmaceuticals
Board Meeting6 Aug 2026, 06:00 pm

Syncom Formulations Board Meeting on Aug 11 to Review Q1 Results

AI Summary

Syncom Formulations India Ltd has announced a Board of Directors meeting scheduled for August 11, 2026. The meeting will primarily focus on considering and approving the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. Additionally, the board will review the limited review report from the auditors for these results and may recommend a final dividend for the financial year ended March 31, 2026. The meeting will take place at the company's corporate office in Indore.

Key Highlights

  • Board meeting scheduled for August 11, 2026.
  • To approve Q1 FY27 unaudited financial results.
  • Consideration of final dividend for FY26.
  • Auditors' limited review report to be taken on record.